Patents by Inventor Anna Svenja Schubart

Anna Svenja Schubart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Uses of piperidinyl-indole derivatives
    Patent number: 11723901
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Grant
    Filed: August 30, 2018
    Date of Patent: August 15, 2023
    Assignee: Novartis AG
    Inventors: Jörg Eder, Richard Alexander Harrison, Boerje Haraldsson, Anna Svenja Schubart
  • NOVEL USES OF PIPERIDINYL-INDOLE DERIVATIVES
    Publication number: 20200338059
    Abstract: The present invention relates to the novel use of certain piperidinyl-indole derivatives in the treatment of patients suffering from renal diseases or disorders, and in particular for the treatment of patients suffering from C3G (C3 glomerulopathy) and IgAN (IgA nephropathy).
    Type: Application
    Filed: August 30, 2018
    Publication date: October 29, 2020
    Inventors: Jörg EDER, Richard Alexander HARRISON, Boerge HARALDSSON, Anna Svenja SCHUBART
  • Use of 1-{4-[1-(4-cyclohexyl-3-trifluoromethyl-benzyloxyimino)-ethyl]-2-ethyl-benzyl}-azetidine-3-carboxylic acid in treating symptoms associated with rett syndrome
    Patent number: 9265754
    Abstract: Use of an S1P receptor modulator in the treatment or prevention of a disease or condition dependent on brain-derived neurotrophic factor (BDNF) expression.
    Type: Grant
    Filed: December 5, 2013
    Date of Patent: February 23, 2016
    Assignee: Novartis AG
    Inventors: Yves-Alain Barde, Graeme Bilbe, Ruben Deogracias, Rainer R. Kuhn, Tomoya Matsumoto, Anis Khusro Mir, Anna Svenja Schubart
  • USE OF S1P RECEPTOR MODULATOR
    Publication number: 20140235610
    Abstract: Use of an S1P receptor modulator in the treatment or prevention of a disease or condition dependent on brain-derived neurotrophic factor (BDNF) expression.
    Type: Application
    Filed: December 5, 2013
    Publication date: August 21, 2014
    Inventors: Yves-Alain BARDE, Graeme BILBE, Ruben DEOGRACIAS, Rainer R. KUHN, Tomoya MATSUMOTO, Anis Khusro MIR, Anna Svenja SCHUBART
  • USE OF S1P RECEPTOR MODULATOR
    Publication number: 20140011884
    Abstract: Use of an S1P receptor modulator in the treatment or prevention of a disease or condirion dependent on brain-derived neurotrophic factor (BDNF) expression.
    Type: Application
    Filed: May 13, 2013
    Publication date: January 9, 2014
    Inventors: Yves-Alain BARDE, Graeme BILBE, Ruben DEOGRACIAS, Rainer R, KUHN, Tomoya MATSUMOTO, Anis Khusro MIR, Anna Svenja SCHUBART
  • USE OF S1P RECEPTOR MODULATOR
    Publication number: 20120245129
    Abstract: Use of an S1P receptor modulator in the treatment or prevention of a disease or condirion dependent on brain-derived neurotrophic factor (BDNF) expression.
    Type: Application
    Filed: December 5, 2011
    Publication date: September 27, 2012
    Inventors: Yves-Alain Barde, Graeme Bilbe, Ruben Deogracias, Rainer R. Kuhn, Tomoya Matsumoto, Anis Khusro Mir, Anna Svenja Schubart